Nephros (NEPH) Return on Capital Employed (2011 - 2026)
Nephros (NEPH) posted quarterly Return on Capital Employed of 6.05% for Q1 2026, down 169.0% year-over-year from 8.77% in Q1 2025, and down 43.64% quarter-over-quarter from 10.73% in Q4 2025.
Nephros (NEPH) Return on Capital Employed (2011 - 2026) Analysis & Trends
Nephros' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 6.05% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 169.0% year-over-year to 6.05%; the TTM figure through Mar 2026 stood at 6.05% (down 169.0% YoY), while the FY2025 annual figure was 11.87%, up 1181.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 6.05%, down from 10.73% in the prior quarter.
- The five-year high for Return on Capital Employed was 14.06% in Q3 2025, with the low at 44.44% in Q4 2022.
- The 5-year median for Return on Capital Employed is 15.31% (2024), against an average of 13.23%.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed sank 2060 bps in 2022, then jumped 2777 bps in 2025.
- Nephros' Return on Capital Employed stood at 44.44% in 2022, then soared by 61 bps to 17.17% in 2023, then jumped by 100 bps to 0.06% in 2024, then jumped by 16422 bps to 10.73% in 2025, then tumbled by 44 bps to 6.05% in 2026.
- Business Quant data shows NEPH's Return on Capital Employed at 6.05% in Q1 2026, 10.73% in Q4 2025, and 14.06% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.76 Bn | 129.55 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.60 Bn | 51.74 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.77 Bn | 34.42 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.93 Bn | 32.47 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.11 Bn | 26.44 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 24.93 Bn | 24.50 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.40 Bn | 14.99 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.85 Bn | 14.71 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.60 Bn | 11.45 Bn | 1.03 Bn | 3.28% |
| 10 | Nephros | 46.14 Mn | 41.44 Mn | 4.03 Mn | 14.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.36% |
| Mar 31, 2026 | 6.05% |
| Dec 31, 2025 | 10.73% |
| Sep 30, 2025 | 14.06% |
| Jun 30, 2025 | 13.06% |
| Mar 31, 2025 | 7.74% |
| Dec 31, 2024 | 0.06% |
| Sep 30, 2024 | -9.91% |
| Jun 30, 2024 | -14.71% |
| Mar 31, 2024 | -15.31% |
| Dec 31, 2023 | -17.17% |
| Sep 30, 2023 | -18.55% |
| Jun 30, 2023 | -28.70% |
| Mar 31, 2023 | -32.40% |
| Dec 31, 2022 | -44.44% |
| Sep 30, 2022 | -37.63% |
| Jun 30, 2022 | -29.58% |
| Mar 31, 2022 | -28.21% |
| Dec 31, 2021 | -23.84% |
| Sep 30, 2021 | -22.73% |